CLS at a Glance

 CLS is a medical technology company based in Lund, Sweden. We are committed to continuously develop more precise treatment tools for laser ablation of diseased tissue, such as tumors. Through our TRANBERG® | Thermal Therapy Systems more patients can be treated based on their specific diagnosis and needs. 

Strategy - Improving Precision in Care

CLS’s vision is that laser ablation will be introduced as standard treatment and as an alternative to surgery for several patient groups. The goal is that tomorrow’s cancer and neurology patients will have access to yet another treatment option that is safe, effective and gives an improved quality of life.


Our History

Read about CLS’ exciting journey from 2006 until now, which started with Professor Karl-Göran Tranberg discovering that laser beams could both destroy cancer and activate the immune system.

Executive management team

CLS' management team has extensive experience in product and business development of medtech products, as well as in cancer care, regulatory work and international marketing.

Board of Directors

CLS' board has extensive experience in the medtech industry and in the commercialization of medtech products, as well as a broad knowledge of oncology, financial markets and economics.


Treating severe diseases as cancer in a precise and careful way is CLS’ driving force. Our exciting journey has started and we continuously add new skills and energy to our dynamic team.

Welcome to Clinical Laserthermia Systems.

Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!

Please choose your country or region